(Q49594691)

21 February 2018

title

NF-κB, inflammation, immunity and cancer: coming of age. (English)

1 reference

21 February 2018

0 references

0 references

2

Michael Karin

1 reference

21 February 2018

Koji Taniguchi

1

1 reference

21 February 2018

publication date

22 January 2018

1 reference

21 February 2018

Nature Reviews Immunology

published in

1 reference

21 February 2018

Inflammation and cancer: back to Virchow?

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

31 March 2020

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Gist of Dr. Katsusaburo Yamagiwa's papers entitled "Experimental study on the pathogenesis of epithelial tumors" (I to VI reports).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Infections as a major preventable cause of human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Global burden of cancers attributable to infections in 2012: a synthetic analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Immunity, Inflammation, and Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Immunity, inflammation, and cancer: an eternal fight between good and evil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Hallmarks of Cancer: The Next Generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Reparative inflammation takes charge of tissue regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Nuclear factor-kappaB in cancer development and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The diverse and complex roles of NF-κB subunits in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB: linking inflammation and immunity to cancer development and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Oncogenic activation of NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation meets cancer, with NF-κB as the matchmaker

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB and the link between inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation and colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammatory networks underlying colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Emerging cytokine networks in colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Regulation and function of NF-kappaB transcription factors in the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The non-canonical NF-κB pathway in immunity and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Crosstalk in NF-κB signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Innate immune responses: crosstalk of signaling and regulation of gene transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Return to homeostasis: downregulation of NF-κB responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Crystal structure of inhibitor of κB kinase β

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Ubiquitination in signaling to and activation of IKK.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

MicroRNAs in NF-kappaB signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

MicroRNAs, new effectors and regulators of NF-κB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Telomerase directly regulates NF-κB-dependent transcription.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Microenvironmental regulation of tumor progression and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Macrophage plasticity and polarization: in vivo veritas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

31 March 2020

Macrophage Polarization.

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

"Re-educating" tumor-associated macrophages by targeting NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Dendritic cells in the cancer microenvironment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κB

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Functions of natural killer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

A role for NF-kappa B activation in perforin expression of NK cells upon IL-2 receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

A novel NF-kappaB binding site controls human granzyme B gene transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Roles of the NF-kappaB pathway in lymphocyte development and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB control of T cell development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

An NF-κB Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and Function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB subunit specificity in hemopoiesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

An IKKα-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The biology and function of fibroblasts in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Mesenchymal Cells in Colon Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Tumour necrosis factor and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Apoptosis: a review of programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Regulated necrosis: the expanding network of non-apoptotic cell death pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Necroptosis and its role in inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The interleukin-1 family: back to the future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Interleukin-33 in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IL-12-and IL-23 in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The IL-6 feed-forward loop: a driver of tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

A gp130-Src-YAP module links inflammation to epithelial regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Targeting IL-10 in auto-immune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The role of the IL-22/IL-22R1 axis in cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The dynamic roles of TGF-β in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Nf-kappa B, chemokine gene transcription and tumour growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Autophagy in immunity and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Role of autophagy in suppression of inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Context-Dependent Regulation of Autophagy by IKK-NF-κB Signaling: Impact on the Aging Process

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

p65/RelA modulates BECN1 transcription and autophagy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammatory signaling and cellular senescence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Cancer secretome and inflammation: The bright and the dark sides of NF-κB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB in cellular senescence and cancer treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB activation impairs somatic cell reprogramming in ageing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation and cancer: tissue regeneration gone awry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Two-signal requirement for growth-promoting function of Yap in hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation and cancer stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Development and maintenance of cancer stem cells under chronic inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB signaling in cancer stem cells: a promising therapeutic target?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The NF-κB Pathway and Cancer Stem Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation: a driving force speeds cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB, inflammation, and metabolic disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB, an active player in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The evolution of the cancer niche during multistage carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

A genetic model for colorectal tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB and cell-cycle regulation: the cyclin connection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

FAT10 mediates the effect of TNF-α in inducing chromosomal instability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation and p53: A Tale of Two Stresses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Suppression of Ras-induced apoptosis by the Rac GTPase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor kappa B transactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The metastatic niche: adapting the foreign soil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Role of hypoxia-inducible factors in breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

TGF-β signalling and its role in cancer progression and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappa B: a new player in angiostatic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Angiogenesis and chronic inflammation: cause or consequence?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Cancer and the chemokine network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Epidemiology of hepatocellular carcinoma: consider the population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Ectopic lymphoid-like structures in infection, cancer and autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

A lymphotoxin-driven pathway to hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Molecular mechanisms of cancer development in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Obesity, Inflammation, and Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Steatosis and steatohepatitis: complex disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Critical role of NF-κB in pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation and pancreatic cancer: an evidence-based review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

KRAS: feeding pancreatic cancer proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Loss of acinar cell IKKα triggers spontaneous pancreatitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Prostate cancer and inflammation: the evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB gene signature predicts prostate cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Inflammation and prostate cancer: the role of interleukin 6 (IL-6).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IKKα controls ATG16L1 degradation to prevent ER stress during inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-kappaB in lung tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Surgery for Cancer: A Trigger for Metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Immunological aspects of cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NSAIDs inhibit tumorigenesis, but how?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The role of STAT3 in tumor-mediated immune suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

STAT3 signaling in immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The emerging safety profile of JAK inhibitors in rheumatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

New pharmacotherapy options for chemotherapy-induced alimentary mucositis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Therapeutic targeting of the interleukin-6 receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The complexity of NF-κB signaling in inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

p53 and the Carcinogenicity of Chronic Inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Role of NF-κB in epithelial biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB and IRF pathways: cross-regulation on target genes promoter level

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Achieving stability of lipopolysaccharide-induced NF-kappaB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Type I interferons in anticancer immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Redox activation of Nrf2 & NF-κB: a double end sword?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

NF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Linking JNK signaling to NF-kappaB: a key to survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Notch and NFkappaB signaling pathways: Do they collaborate in normal vertebrate brain development and function?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Microbiome, inflammation, and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Microbiota: a key orchestrator of cancer therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The role of the microbiota in inflammation, carcinogenesis, and cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The microbiome and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Gut Microbiota, Inflammation, and Colorectal Cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Gut microbiota, inflammation and colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Development and maintenance of intestinal regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

The microbiota in adaptive immune homeostasis and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.142

Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis

31 March 2020

1 reference

12 December 2020

The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus

1 reference

12 December 2020

Function of nuclear factor kappaB in pancreatic cancer metastasis

1 reference

12 December 2020

Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology

1 reference

12 December 2020

The M1 and M2 paradigm of macrophage activation: time for reassessment

1 reference

12 December 2020

STAT3 and epithelial-mesenchymal transitions in carcinomas

1 reference

12 December 2020

The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis.

1 reference

12 December 2020

Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI.2017.142

1 reference

21 February 2018

1 reference

21 February 2018